| | | | | |
| €26,8242 | -1,73% | €240,70M | €41,83K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | €12,1078 | -0,21% | €240,41M | €12,31K | |
TSI TCW Strategic Income Fund, Inc. | €3,7756 | +0,00% | €240,01M | €115,23K | |
PAII Pyrophyte Acquisition Corp. II | €8,8213 | +0,00% | €239,59M | €1,41K | |
| €12,9916 | +6,25% | €239,47M | €615,10K | |
YDES YD Bio Limited Ordinary Shares | €3,6555 | -8,97% | €239,47M | €9,75K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | €8,5724 | -0,10% | €239,16M | €5,12K | |
RWAY Runway Growth Finance Corp. Common Stock | €5,6120 | -0,31% | €239,15M | €237,91K | |
JILL J.Jill, Inc. Common Stock | €17,0419 | +0,51% | €239,14M | €71,98K | |
LCTX Lineage Cell Therapeutics, Inc. | €0,96957 | -0,01% | €238,72M | €684,10K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | €8,8513 | -0,15% | €238,65M | €59,77K | |
ACV Virtus Diversified Income & Convertible Fund | €22,6796 | -0,49% | €238,63M | €41,85K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,6905 | -1,50% | €238,49M | €330,41K | |
| €1,1584 | -6,25% | €238,41M | €652,86K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | €2,4971 | -1,69% | €238,26M | €41,87K | |
